Volatile Week, but Green? Click to watch the new Podcast.

Arbutus Biopharma Corporation Stock Forecast

NASDAQ:ABUS BUY SELL

$2.88 (2.86%)

Volume: 1.572M

Closed: Jul 05, 2022

Hollow Logo Score: 3.624

Arbutus Biopharma Corporation Stock Forecast

BUY SELL NASDAQ:ABUS
$2.88 (2.86%)

Volume: 1.572M

Closed: Jul 05, 2022

Score Hollow Logo 3.624

Arbutus Biopharma Corporation Stock Price (Quote) NASDAQ:ABUS

$2.88 ( 2.86% ) Tuesday, 5th Jul 2022

Range Low Price High Price Comment
30 days $2.29 $2.99 Tuesday, 5th Jul 2022 ABUS stock ended at $2.88. This is 2.86% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 7.87% from a day low at $2.77 to a day high of $2.99.
90 days $1.93 $3.07
52 weeks $1.93 $6.50

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2022-07-05 $2.79 $2.99 $2.77 $2.88 1 571 864
2022-07-01 $2.69 $2.82 $2.69 $2.80 715 810
2022-06-30 $2.62 $2.76 $2.62 $2.71 586 547
2022-06-29 $2.57 $2.70 $2.52 $2.70 553 688
2022-06-28 $2.66 $2.71 $2.58 $2.61 674 621
2022-06-27 $2.80 $2.86 $2.63 $2.68 928 077
2022-06-24 $2.95 $2.95 $2.80 $2.84 2 697 962
2022-06-23 $2.75 $2.94 $2.72 $2.92 1 222 671
2022-06-22 $2.69 $2.85 $2.65 $2.74 822 041
2022-06-21 $2.70 $2.86 $2.68 $2.72 1 331 255
2022-06-17 $2.57 $2.76 $2.54 $2.68 1 784 357
2022-06-16 $2.48 $2.61 $2.39 $2.57 1 295 331
2022-06-15 $2.44 $2.61 $2.42 $2.55 1 110 654
2022-06-14 $2.38 $2.45 $2.32 $2.43 549 092
2022-06-13 $2.42 $2.45 $2.29 $2.38 949 193
2022-06-10 $2.60 $2.61 $2.42 $2.52 812 196
2022-06-09 $2.67 $2.71 $2.62 $2.65 610 838
2022-06-08 $2.63 $2.82 $2.63 $2.68 729 094
2022-06-07 $2.54 $2.70 $2.48 $2.70 582 474
2022-06-06 $2.73 $2.74 $2.48 $2.56 1 111 354
2022-06-03 $2.60 $2.73 $2.54 $2.70 749 517
2022-06-02 $2.46 $2.60 $2.43 $2.60 871 003
2022-06-01 $2.43 $2.56 $2.41 $2.46 953 846
2022-05-31 $2.45 $2.49 $2.38 $2.43 1 203 608
2022-05-27 $2.32 $2.50 $2.27 $2.48 1 075 310
2022-05-26 $2.22 $2.38 $2.22 $2.31 771 528
2022-05-25 $2.19 $2.27 $2.17 $2.25 794 302
2022-05-24 $2.37 $2.37 $2.18 $2.19 1 181 864
2022-05-23 $2.44 $2.47 $2.34 $2.40 869 960
2022-05-20 $2.32 $2.51 $2.30 $2.44 1 471 126
2022-05-19 $2.31 $2.43 $2.28 $2.34 1 275 337
2022-05-18 $2.34 $2.45 $2.30 $2.31 1 047 592
2022-05-17 $2.28 $2.42 $2.25 $2.41 1 090 270
2022-05-16 $2.27 $2.38 $2.22 $2.26 745 559
2022-05-13 $2.09 $2.35 $2.08 $2.31 1 712 394
2022-05-12 $2.02 $2.17 $1.97 $2.06 2 151 819
2022-05-11 $1.95 $2.22 $1.94 $2.06 2 020 862
2022-05-10 $2.34 $2.36 $1.93 $1.98 3 269 193
2022-05-09 $2.46 $2.47 $2.22 $2.23 1 467 819
2022-05-06 $2.55 $2.60 $2.45 $2.53 1 043 530
2022-05-05 $2.59 $2.59 $2.42 $2.55 1 248 573
2022-05-04 $2.42 $2.50 $2.28 $2.49 1 059 993
2022-05-03 $2.42 $2.51 $2.39 $2.42 671 797
2022-05-02 $2.37 $2.49 $2.33 $2.44 1 357 098
2022-04-29 $2.40 $2.51 $2.33 $2.33 570 329
2022-04-28 $2.46 $2.49 $2.26 $2.43 1 395 384
2022-04-27 $2.49 $2.53 $2.42 $2.43 702 242
2022-04-26 $2.57 $2.62 $2.48 $2.48 842 652
2022-04-25 $2.53 $2.68 $2.53 $2.63 1 244 495
2022-04-22 $2.48 $2.59 $2.45 $2.57 1 633 101

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 555 stocks, only a few dozen will trigger such a signal!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). Its lead candidate is ARB-1467, a multi-component RNAi therapeutic product that is designed for the elimination of HBV surface antigen expression in patients chronically i... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT